A 35-year-old multiparous woman with a history of one episode of pelvic inflammatory disease (PID) 4 years ago (treated with antibiotics, resolved) attends the clinic for contraceptive counseling. She has completed her family and desires a highly effective, long-acting reversible method. She has no current symptoms or signs of infection, and her cervical swab for chlamydia and gonorrhea is negative. Her last menstrual period was 10 days ago. Which IUCD is most appropriate for this patient?

Explanation

## Clinical Context: IUCD and History of PID This question addresses a **common misconception** in contraceptive practice: the belief that a history of PID is an absolute or relative contraindication to IUCD insertion. ## Current Evidence and Guidelines **Key Point:** A **history of PID is NOT a contraindication** to IUCD insertion, provided: 1. **The episode was treated and resolved** — no ongoing infection 2. **Current cervical screening is negative** — no active STI (chlamydia, gonorrhea) 3. **No signs or symptoms of active infection** — asymptomatic at insertion 4. **Low risk of future STI** — monogamous relationship or consistent barrier use **High-Yield:** Both **copper IUCDs and LNG-IUS are safe** in women with a remote history of PID. The risk of recurrent PID after IUCD insertion is **not significantly elevated** compared to women without prior PID, provided they are in low-risk sexual partnerships [cite:WHO MEC 5e, ACOG 2019]. ## Why This Patient Is Suitable | Criterion | Status | Implication | | --- | --- | --- | | **Prior PID** | Yes, 4 years ago | Remote; treated and resolved | | **Current infection screen** | Negative (chlamydia, gonorrhea) | No active STI | | **Current symptoms** | None | No sign of active PID | | **Sexual risk** | Presumed low (multiparous, stable) | Suitable for IUCD | | **Timing** | 10 days post-menses | Optimal window for insertion | ## Choice Between Copper T 380A and LNG-IUS **Clinical Pearl:** For this patient, **either copper T 380A or LNG-IUS would be appropriate**. The choice depends on: - **Menstrual pattern**: If she has normal/light menses → Copper T 380A (no hormones, 10-year duration) - **Menstrual symptoms**: If she has heavy menses or dysmenorrhea → LNG-IUS (therapeutic benefit) - **Patient preference**: Hormonal vs. non-hormonal Since the stem does not specify her menstrual history, **Copper T 380A is the most straightforward correct answer** — it is the most commonly recommended first-line IUCD for women with uncomplicated contraceptive needs and is explicitly safe in this clinical context. ## Myth-Busting: Why Old Beliefs Are Wrong **Warning:** The outdated teaching that "PID is a contraindication to IUCD" stems from: 1. **Early observational data** (1970s–1980s) showing increased PID risk in IUCD users — but this was confounded by **increased STI exposure** (IUCD users had more partners), not the device itself 2. **Misinterpretation of causation** — the IUCD did not cause PID; rather, women at higher STI risk were more likely to use IUCDs 3. **Modern evidence** (prospective, controlled studies) shows no increased PID incidence in IUCD users vs. other contraceptive methods when STI risk is controlled **Key Point:** The **IUCD does not increase susceptibility to PID** in women without active STI. The device itself is inert (copper) or locally hormonal (LNG-IUS) and does not impair local or systemic immunity. ## WHO/ACOG Classification WHO Medical Eligibility Criteria (MEC) classify a history of PID as: - **Category 2** (advantages generally outweigh risks) for copper IUCDs - **Category 2** for LNG-IUS This means IUCD insertion is **safe and can be recommended** with standard counseling and STI screening. ## Timing of Insertion **Tip:** Insertion is optimal **within 5 days of menses onset** (to exclude early pregnancy and ensure cervical dilation). This patient is 10 days post-menses, so she may need to: - Return during her next menstrual period for insertion, OR - Have a negative pregnancy test and be inserted now (acceptable if pregnancy excluded) There is **no need to wait 12 months** after PID resolution.